Related Experiment Video
Updated: Mar 30, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Fecal microbiota transplantation: current clinical efficacy and future prospects
Kathryn A Bowman1, Elizabeth K Broussard2, Christina M Surawicz2
1Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Abstract:
Fecal microbiota transplantation (FMT) has gained mainstream attention with its remarkable efficacy in treating recurrent Clostridium difficile infection (RCDI) when there are no other effective therapies. Methods of selecting donors and routes of administration vary among studies, but there are now randomized controlled trials showing efficacy of FMT in treating RCDI. Ongoing trials of FMT for other disease such as inflammatory bowel disease are underway; this therapy should not be used for these conditions unless there is strong evidence for efficacy. Long-term safety data are sorely needed, as well as clarification of regulatory concerns.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Introduction to the Human Microbiota
What is Monogastric Digestion?
Development of Human Microbiota
Microbiota of the Large Intestine
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.

